According to MarketsandMarkets™, the latest report, “Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique (Transcriptomics (IHC, ISH), Genomics (LCM), Service Type (Sample Prep, Sequencing), Application (Translational Research (Cancer)) – Global Forecast to 2029,” the market is projected to grow from USD 554.5 million in 2024 to USD 995.7 million by 2029, registering a strong CAGR of 12.4%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551
What is fueling this accelerated market expansion, and why is it critical now?
The increasing integration of spatial genomics and transcriptomics into drug discovery and development workflows is a primary growth driver. These technologies enable researchers to map gene expression within tissue architecture, providing deeper biological insights that are essential for developing targeted therapies. Additionally, the introduction of technologically advanced instruments is enhancing analytical capabilities, making spatial biology more accessible and scalable across research and clinical environments.
How are product innovations influencing market dynamics?
The consumables segment accounted for the largest share of the market in 2023, driven by the growing demand for high-quality reagents and kits used in multi-omics workflows. As research increasingly relies on integrated omics approaches, precise and reliable sample preparation has become indispensable. This has led to a surge in demand for consumables that ensure data integrity and reproducibility, particularly in complex genomic and transcriptomic analyses.
Which applications are leading adoption?
The translational research segment dominated the market in 2023, reflecting the growing use of spatial technologies to bridge the gap between laboratory research and clinical applications. By enabling high-throughput analysis of cellular organization and gene activity within tissues, spatial transcriptomics provides critical insights into disease mechanisms, particularly in oncology. Increased funding from government and non-government organizations, along with expanding use cases in cancer research, continues to drive this segment forward.
Where is the market gaining the most traction?
North America accounted for the largest share of the spatial genomics and transcriptomics market in 2023. This leadership position is supported by strong R&D investments, robust government funding, continuous technological advancements, and frequent product launches. While Europe remains a significant contributor, North America’s advanced research infrastructure and early adoption of innovative technologies continue to set the pace for global market growth.
Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170900551
Who are the key players shaping innovation and competition in this space?
Leading companies in the spatial genomics & transcriptomics market include NanoString Technologies, Inc. (Bruker Spatial Biology, Inc.) (US), 10x Genomics (US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Bio-Techne (US), Standard BioTools (US), Akoya Biosciences, Inc. (US), Danaher Corporation (US), Macrogen, Inc. (South Korea), and Seven Bridges Genomics (US). These players are actively investing in next-generation platforms, strategic collaborations, and product innovation to strengthen their market presence and address evolving research demands.
Related Reports:
Genomics Market - Global Forecast to 2030
Immunohistochemistry Market - Global Forecast to 2030
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com
